MAPT and Alzheimer disease: Here, we used a mouse model in which endogenous tau is seeded to produce AD-like tau features via sarkosyl-insoluble tau aggregates isolated from the frontal cortex of human AD brain tissue to specifically investigate the effects of TREM2 deficiency on tau spreading [20].